Analysis reveals reduced apheresis procedures and costs for hematopoietic progenitor cell collection in myeloma and lymphoma patients, suggesting improved efficiency.
Key Points
Changing autologous HPC collection goals decreased costs and workload significantly.
Patient averages for LVL procedures dropped from two to one, indicating improved resource allocation.
Significant decreases in cryopreserved bags and staffing hours were observed per patient in 2023.
Comparisons to control periods showed consistent reductions in apheresis and CTL services.